 |
Abcuro
Founder Stefano Gullà
USA | Funding: $414.8M (+)
Website: https://www.abcuro.com/
Abcuro develops first-in-class immunotherapies to treat autoimmunity and cancer.
Website: https://www.abcuro.com/
Abcuro develops first-in-class immunotherapies to treat autoimmunity and cancer.
